摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-tert-Butyl-N-[6-chloro-5-(3-methoxy-phenoxy)-2-methyl-pyrimidin-4-yl]-benzenesulfonamide | 189574-47-8

中文名称
——
中文别名
——
英文名称
4-tert-Butyl-N-[6-chloro-5-(3-methoxy-phenoxy)-2-methyl-pyrimidin-4-yl]-benzenesulfonamide
英文别名
4-tert-butyl-N-[6-chloro-5-(3-methoxyphenoxy)-2-methylpyrimidin-4-yl]benzenesulfonamide
4-tert-Butyl-N-[6-chloro-5-(3-methoxy-phenoxy)-2-methyl-pyrimidin-4-yl]-benzenesulfonamide化学式
CAS
189574-47-8
化学式
C22H24ClN3O4S
mdl
——
分子量
461.969
InChiKey
VOGWDGTWVKQZDZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.6
  • 重原子数:
    31
  • 可旋转键数:
    7
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.27
  • 拓扑面积:
    98.8
  • 氢给体数:
    1
  • 氢受体数:
    7

反应信息

  • 作为反应物:
    描述:
    4-tert-Butyl-N-[6-chloro-5-(3-methoxy-phenoxy)-2-methyl-pyrimidin-4-yl]-benzenesulfonamide 在 sodium hydride 、 pyridinium chlorochromate 作用下, 以 二氯甲烷 为溶剂, 反应 8.5h, 生成 4-tert-Butyl-N-[5-(3-methoxy-phenoxy)-2-methyl-6-(4-oxo-butoxy)-pyrimidin-4-yl]-benzenesulfonamide
    参考文献:
    名称:
    Synthesis and structure–activity relationships of potent and orally active sulfonamide ETB selective antagonists
    摘要:
    The synthesis and structure-activity relationships of a series of N-pyrimidinyl benzenesulfonamides as ETB selective antagonists are described. N-Isoxazolyl benzenesulfonamide 1a. previously reported,(1) was selected as a lead compound, and isosteric replacement of the isoxazole ring of la with a pyrimidine ring led to the discovery of the highly potent ETB selective antagonist 6e with oral bioavailability. Modification of the terminal aldehyde group at the 6-position of the pyrimidine ring was investigated, and malonate 15b and acylhydrazone 16f were found to be equipotent to aldehyde 6e. Compound 6e showed ETB antagonistic activity on in vivo evaluation. (C) 2001 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0968-0896(00)00305-9
  • 作为产物:
    参考文献:
    名称:
    Synthesis and structure–activity relationships of potent and orally active sulfonamide ETB selective antagonists
    摘要:
    The synthesis and structure-activity relationships of a series of N-pyrimidinyl benzenesulfonamides as ETB selective antagonists are described. N-Isoxazolyl benzenesulfonamide 1a. previously reported,(1) was selected as a lead compound, and isosteric replacement of the isoxazole ring of la with a pyrimidine ring led to the discovery of the highly potent ETB selective antagonist 6e with oral bioavailability. Modification of the terminal aldehyde group at the 6-position of the pyrimidine ring was investigated, and malonate 15b and acylhydrazone 16f were found to be equipotent to aldehyde 6e. Compound 6e showed ETB antagonistic activity on in vivo evaluation. (C) 2001 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0968-0896(00)00305-9
点击查看最新优质反应信息

文献信息

  • N-(Pyrimidinyl)-benzolsulfonamide als Arzneimittel
    申请人:F. HOFFMANN-LA ROCHE AG
    公开号:EP0768304A1
    公开(公告)日:1997-04-16
    Verbindungen der allgemeinen Formel    worin R1-R6, Ra, Rb, X, Y, Z, m und n die in der Beschreibung gegebene Bedeutung haben, können als Heilmittel, insbesondere zur Behandlung von mit Endothelinaktivitäten assozierten Aktivitätenzuständen, Verwendung finden.
    通式如下的化合物 其中 R1-R6、Ra、Rb、X、Y、Z、m 和 n 具有说明中给出的含义、 可用作治疗剂,特别是用于治疗与内皮素活性相关的活动状态。
  • Synthesis and structure–activity relationships of potent and orally active sulfonamide ETB selective antagonists
    作者:Yasuhiko Kanda、Yasuyuki Kawanishi、Katsuo Oda、Teruo Sakata、Shin-ichi Mihara、Kenji Asakura、Toshiyuki Kanemasa、Mitsuyoshi Ninomiya、Masafumi Fujimoto、Toshiro Konoike
    DOI:10.1016/s0968-0896(00)00305-9
    日期:2001.4
    The synthesis and structure-activity relationships of a series of N-pyrimidinyl benzenesulfonamides as ETB selective antagonists are described. N-Isoxazolyl benzenesulfonamide 1a. previously reported,(1) was selected as a lead compound, and isosteric replacement of the isoxazole ring of la with a pyrimidine ring led to the discovery of the highly potent ETB selective antagonist 6e with oral bioavailability. Modification of the terminal aldehyde group at the 6-position of the pyrimidine ring was investigated, and malonate 15b and acylhydrazone 16f were found to be equipotent to aldehyde 6e. Compound 6e showed ETB antagonistic activity on in vivo evaluation. (C) 2001 Elsevier Science Ltd. All rights reserved.
查看更多